Hub Name.

Mar 17, 2022 · Enveda Biosciences, a leading biotechnology company harnessing nature’s chemistry to develop next-generation small molecule therapies, today announced.

D. .



, where he spent more than a decade. . Viswa Colluru, CEO and Founder of Enveda Biosciences.

Hub Name.

. Edit Related Hubs Section. Aug 21, 2020 · Developer of a drug discovery platform designed to capitalize on the chemical diversity and evolutionary significance of nature's hidden chemistry to create high-value small-molecule medicines.

. Enveda Biosciences's Founder and CEO is Viswa Colluru.

, Ph.


. the company’s Founder and CEO.

Technology Networks recently interviewed Viswa Colluru, founder and CEO of Enveda Biosciences, to find out how the company is “harnessing the complexity of. .

For Enveda Biosciences and its founder and CEO Viswa Colluru, PhD, molecules have fingerprints which speak a language we can understand and use to translate into previously entirely unknown.
, April 20, 2023--Enveda Biosciences today announced that it has closed an additional $51 million equity financing to add to the $68 million Series B announced in December 2022.

Aug 16, 2021 · Enveda Biosciences, a leading biotechnology company harnessing the power of nature’s chemistry to develop next-gen small molecule therapeutics, today.


. Hub Name. .

. . . Found 45 of over 46 reviews. As CMO, identified to lead an autonomous R&D unit within Lilly specializing in lead. , where he spent more than a decade.

Oct 25, 2022 · Enveda Biosciences today announced the appointment of industry leader Mark Deeg, M.

Karathanasis will accelerate Enveda’s current portfolio in metabolic and. Ph.




, as the company's Chief Medical Officer.

Their latest funding was raised on Apr 20, 2023 from a Series B round.